whatshot

VIGL   $3.85  -2.78% Market Closed

Vigil Neuroscience Inc
show_chart Advanced Chart of VIGL
Last Events:

2023-08-09 Trend pattern changed from расширяющаяся формация to нисходящий клин.

2023-08-06 Trend pattern changed from расходящийся треугольник to расширяющаяся формация.

2023-08-06 Signal in MACD changed from bearish weakening to bearish recovery. Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: main and signal line crossing.

2023-08-06 Signal in RSI changed from bearish weakening to bearish recovery. RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

2023-08-06 Trend Power changed from slow to medium strength.

2023-08-05 Signal in MACD changed from bearish recovery to bearish weakening. Oscillator MACD is in the negative territory it's lower than the signal line and grows. These factors mean that the falling trend persists, but the growth rate is declining. Last signal: main and signal line crossing.

2023-08-05 Signal in RSI changed from bearish recovery to bearish weakening. RSI indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: exit from the overbought zone.

2023-08-05 Trend Power changed from medium strength to slow.

Current temperature: 7.86
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 8
Target Price Mean 15.88
Mean unverified/preliminary 15.88 / 15.88
Target Price Low / High 4.00 / 23.00
Median / STD DEV 16.50 / 6.47
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total None Sell Sell
rsi Sell Sell Sell
macd None None None
stoch None None None
ma20 ActivelyBuy Sell Sell
ma50 None None None
ma100 Buy Sell None
Candlestick PatternOct. 8, 2024 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US92673K1088
ceo Dr. Ivana Magovcevic-Liebisch J.D., Ph.D.
Website https://www.vigilneuro.com
Vigil Neuroscience, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. Its lead candidate is VGL101(Iluzanebart), a human monoclonal antibody agonist targeting human triggering receptor expressed on myeloid cells 2 and is in a Phase 2 trial in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a rare and fatal neurodegenerative disease. The company is also developing VG-3927, an orally-available small molecule TREM2 agonist to treat common neurodegenerative diseases associated with microglial dysfunction, with an initial focus on Alzheimer's disease in genetically defined subpopulations, which is being evaluated in a Phase 1 clinical trial. It has license agreement with Amgen Inc. to commercially develop, manufacture, use, distribute, and sell therapeutic products containing compounds that bind to TREM2. The company was incorporated in 2020 and is headquartered in Watertown, Massachusetts.